UBS Global Life Sciences Conference, Day 1: Illumina, Agilent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The UBS Global Life Sciences Conference kicked off today in New York with a number of life science tools firms and molecular diagnostics companies making their pitches to the investor community.

Below is a summary of what some vendors had to say during the morning sessions.

Illumina

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.